ArticleBMC nephrology2026
Educational support programs for individuals with end-stage renal disease on hemodialysis: a scoping review.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe global prevalence of End-Stage Renal Disease (ESRD) is increasing, with estimates suggesting that more than 5 million people worldwide require renal replacement therapy (RRT), and this burden falls disproportionately on low- and middle-income countries (LMICs), highlighting the urgent need for effective strategies to support patient self-management. This scoping review synthesizes evidence on the types, delivery methods, and reported outcomes of educational support programs for individuals with ESRD undergoing hemodialysis (HD).
methodsThis review followed the six-stage methodological framework by Arksey and O'Malley and adhered to the PRISMA Extension for Scoping Reviews guidelines. Studies examining educational interventions for ESRD patients on HD were included. A comprehensive search of MEDLINE, CINAHL, Scopus, PubMed, and Web of Science was conducted for English-language articles published between 2011 and 2021. Search terms included combinations of "end-stage renal disease," "ESRD," "hemodialysis," and "haemodialysis" with "educational program," "support program," "patient education," and related terms. Pairs of reviewers independently screened titles and abstracts and assessed full-text articles, resolving discrepancies through group discussion. Data were extracted using a standardized form capturing key study characteristics and synthesized using descriptive statistics and content analysis.
resultsEighteen studies (n = 18) from ten countries met the inclusion criteria. All studies reported that educational interventions, regardless of delivery mode or design, positively influenced quality of life (QOL) and treatment adherence among ESRD patients. Specifically, improvements were documented in serum phosphate control, intradialytic weight gain, psychological well-being (anxiety, depression, stress), self-esteem, dietary knowledge, and physical functioning. Structured self-management programs, particularly those incorporating nutritional education and psychological support, demonstrated the greatest breadth of benefit across clinical and psychosocial domains.
conclusionThis review maps the evidence on educational support programs for HD patients, revealing variability in intervention types, delivery methods, study designs, and outcome measures. These inconsistencies highlight the need for more rigorous, standardized research particularly in LMICs to determine the most effective educational strategies. The findings provide a foundation for developing evidence-based, patient-centered educational programs adaptable to diverse global populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.